EMILY ALVO: Open Payments
NPI 1376276782 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 79 payments from 16 companies in 2025. Trend: 2023 $380 · 2024 $541 · 2025 $1,719
Food & beverage: $1,668Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $504 |
| Janssen Biotech, Inc. | 17 | $351 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $136 |
| Ipsen Biopharmaceuticals, Inc | 5 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| Madrigal Pharmaceuticals | 3 | $68 |
| Mirum Pharmaceuticals, Inc. | 3 | $63 |
| Celltrion USA Inc. | 3 | $62 |
| RedHill Biopharma Inc. | 2 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
Products named: TREMFYA, RINVOQ, MAVYRET, XIFAXAN, IQIRVO, ENTYVIO, REZDIFFRA, Livmarli.
Industry payments across CA — which companies pay providers there.
